NP Final Exam Master Study Guide: Mental Health and Pain Management

Neurobiological Underpinnings:
- Major depression is associated with a decrease in key neurotransmitters within the central nervous system: Serotonin, Norepinephrine, and Dopamine.
- There is a significant physiological link between chronic stress and depression; chronic stress leads to increased levels of cortisol, which is a known contributor to the depressive state.
Clinical Presentation:
- Common Symptoms: Characterized by a persistently depressed mood and anhedonia (the inability to feel pleasure).
- Vegetative and Cognitive Symptoms: Patients frequently experience changes in sleep patterns (insomnia or hypersomnia), appetite fluctuations, and poor concentration.
Critical Complications:
- The greatest and most severe complication of depression is suicide risk.
- Clinical Pearl: It is mandatory to always assess suicide risk in any patient presenting with depression.

Pattern of Occurrence:
- Generalized Anxiety Disorder (GAD): Characterized by persistent and excessive worry.
- Panic Disorder: Characterized by sudden, episodic attacks of intense fear.
Duration and Timing:
- GAD: Symptoms must persist for a duration of $\ge 6$ months to meet diagnostic criteria.
- Panic Disorder: Attacks typically last for minutes and peak rapidly.
Symptom Profiles:
- GAD: Primary physical symptoms include restlessness and significant muscle tension.
- Panic Disorder: Physical symptoms often mimic cardiac or respiratory distress, including palpitations, chest pain, and shortness of breath (SOB).
Trigger Mechanisms:
- GAD: There is often no specific trigger identified for the persistent worry.
- Panic Disorder: Attacks may occur unexpectedly and without an apparent external trigger.
Differential Diagnosis Clinical Pearl:
- Chest pain resulting from a panic attack is considered a diagnosis of exclusion. Primary cardiac causes must be ruled out first before attributing symptoms to anxiety.

Dopamine Hypothesis:
- Schizophrenia is thought to involve excess dopamine activity, specifically localized in the mesolimbic pathway of the brain.
Positive Symptoms ("Added" Behaviors):
- Includes hallucinations (sensory perceptions without external stimuli).
- Includes delusions (fixed false beliefs).
- Includes disorganized speech.
Negative Symptoms (Loss of Normal Function):
- Flat Affect: A lack of emotional expression, often evidenced by a diminished range of facial expressions or vocal inflection.
- Social Withdrawal: Detachment from social circles and activities.
- Lack of Motivation: Reduced drive to initiate or complete goal-directed activities.

Therapeutic Role:
- SSRIs serve as the first-line treatment modality for both depression and various anxiety disorders.
Pharmacological Examples:
- Sertraline
- Escitalopram
- Fluoxetine
Clinical Monitoring and Considerations:
- Delayed Efficacy: SSRIs require several weeks of consistent administration before the full therapeutic effect is realized.
- Serotonin Syndrome: Clinicians must monitor for signs of serotonin syndrome, a potentially life-threatening condition.
- Suicidality: There is an increased risk of suicidal thoughts during the initiation of SSRI therapy, particularly in younger patient populations.

Acute Pain:
- Characterized by a short duration.
- Serves a protective physiological purpose (e.g., pain following a Bone Fracture).
Chronic Pain:
- Defined as pain persisting for a duration of > 3 months (e.g., pain associated with Osteoarthritis).
Neuropathic Pain:
- Caused by injury to or dysfunction of the nervous system.
- Described as burning, shooting, electric, or tingling sensations (e.g., Diabetic Neuropathy).
- Clinical Pearl: Neuropathic pain typically responds poorly to opioids when used as a monotherapy.
Referred Pain:
- Pain that is perceived in a location other than the site of the painful stimulus (e.g., a Myocardial Infarction [MI] manifested as jaw pain).
Ischemic Pain:
- Resulting from reduced blood flow and oxygenation to tissues (e.g., Angina).
Deafferentation Pain:
- A specific subset of pain occurring after the loss of sensory nerve input.
- Examples include Phantom limb pain and post-stroke pain syndrome.

Pharmacological Interventions:
- Because neuropathic pain involves the nervous system rather than standard inflammatory or nociceptive pathways, it is often treated with non-opioid medications:
  - Gabapentin
  - Pregabalin
  - Duloxetine
  - Tricyclic Antidepressants (TCAs)

Risk Factors for Toxicity:
- Lithium toxicity is most commonly precipitated by hyponatremia (low sodium levels) and dehydration.
- Decreased sodium levels cause the kidneys to retain lithium, leading to toxic accumulation.
Clinical Manifestations of Toxicity:
- Tremor
- Confusion
- Ataxia (lack of muscle coordination)
- Nausea
- Seizures (in severe cases)
Maintenance Requirements:
- Patients on Lithium must maintain adequate sodium intake and consistent hydration status to prevent toxicity.

Diagnostic Association Summary ("See This… Think This…"):
- Burning/shooting pain: Indicates Neuropathic pain.
- Flat affect combined with hallucinations: Indicates Schizophrenia.
- Persistent worry lasting $\ge 6$ months: Indicates Generalized Anxiety Disorder.
- Sudden onset of chest pain, palpitations, and fear: Indicates a Panic attack.
- Lithium use in a patient with hyponatremia: Indicates a high risk for Lithium toxicity.
Common Exam Pitfalls:
- Cortisol: Remember that depression is associated with increased cortisol levels, not decreased.
- Lithium and Sodium: Lithium toxicity is worsened and triggered by hyponatremia, not hypernatremia.
- Symptom Classification: In schizophrenia, positive symptoms are behaviors that are "added" to the personality, while negative symptoms represent the loss or absence of normal functions.
- Anxiety Differentiation: Panic attacks are characterized by a sudden peak within minutes, which distinguishes them from the chronic, persistent nature of GAD.